Montreal cognitive assessment in primary sjogren’s syndrome

References

1. ↵
   1. Moutsopoulos HM,
   2. Sjogren's syndrome

   (2001) Harrison's principles of internal medicine (McGraw-Hill, New York (NY)), 15th ed, 1947-1948.
2. ↵
   1. Soliotis FC,
   2. Mavragani CP,
   3. Moutsopoulos HM

   (2004) Central nervous system involvement in Sjogren's syndrome. Ann Rheum Dis 63, 616–620.
3. ↵
   1. Fauchais AL,
   2. Magy L,
   3. Vidal E

   (2012) Central and peripheral neurological complications of primary Sjögren's syndrome. Presse Med 41, e485–e493.
4. ↵
   1. Malinow KL,
   2. Molina R,
   3. Gordon B,
   4. Selnes O,
   5. Provost TT,
   6. Alexander EL

   (1985) Neuropsychiatric dysfunction in primary Sjögren's syndrome. Ann Intern Med 103, 344–350.
5. ↵
   1. Lafitte C,
   2. Amoura Z,
   3. Cacoub P

   (2001) Neurological complications of primary Sjögren's syndrome. J Neurol 248, 577–584.
6. ↵
   1. Belin C,
   2. Moroni C,
   3. Caillat-Vigneron N,
   4. Debray M,
   5. Baudin M,
   6. Dumas JL,
   7. et al.

   (1999) Central nervous system involvement in Sjögren's syndrome:evidence from neuropsychological testing and HMPAO-SPECT. Ann Med Interne (Paris) 150, 598–604.
7. ↵
   1. Martínez S,
   2. Cáceres C,
   3. Mataró M,
   4. Escudero D,
   5. Latorre P,
   6. Dávalos A

   (2010) Is there progressive cognitive dysfunction in Sjögren Syndrome?A preliminary study.? Acta Neurol Scand 122, 182–188.
8. ↵
   1. Le Guern V,
   2. Belin C,
   3. Henegar C,
   4. Moroni C,
   5. Maillet D,
   6. Lacau C,
   7. et al.

   (2010) Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome:a case-control study. Ann Rheum Dis 69, 132–137.
9. ↵
   1. Mataró M,
   2. Escudero D,
   3. Ariza M,
   4. Sánchez-Ojanguren J,
   5. Latorre P,
   6. Junqué C,
   7. et al.

   (2003) Magnetic resonance abnormalities associated with cognitive dysfunction in primary Sjögren's syndrome. J Neurol 250, 1070–1076.
10. ↵
    1. Rodriguez DN,
    2. Hora JS,
    3. Salgado MC,
    4. Paes RA,
    5. Vasconcelos CC,
    6. Landeria-Fernandez J,
    7. et al.

    (2014) A short neuropsychological evaluation of patients with primary Sjögren's syndrome. Arq Neuropsiquiatr 72, 38–43.
11. ↵
    1. Morgen K,
    2. McFarland HF,
    3. Pillemer SR

    (2004) Central nervous system disease in primary Sjogrens syndrome:the role of magnetic resonance imaging. Semin Arthritis Rheum 34, 623–630.
12. 1. Delalande S,
    2. de Seze J,
    3. Fauchais AL,
    4. Hachulla E,
    5. Stojkovic T,
    6. Ferriby D,
    7. et al.

    (2004) Neurologic manifestations in primary Sjogrens syndrome:a study of 82 patients. Medicine (Baltimore) 83, 280–291.
13. ↵
    1. Harboe E,
    2. Beyer MK,
    3. Greve OJ,
    4. Gøransson LG,
    5. Tjensvoll AB,
    6. Kvaløy JT,
    7. et al.

    (2009) Cerebral white matter hyperintensities are not increased in patients with primary Sjögren's syndrome. Eur J Neurol 16, 576–581.
14. ↵
    1. Blanc F,
    2. Longato N,
    3. Jung B,
    4. Kleitz C,
    5. Di Bitonto L,
    6. Cretin B,
    7. et al.

    (2013) Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome. ISRN Neurol 2013, 501327.
15. ↵
    1. Nasreddine ZS,
    2. Phillips NA,
    3. Bédirian V,
    4. Charbonneau S,
    5. Whitehead V,
    6. Collin I,
    7. et al.

    (2005) The Montreal Cognitive Assessment, MoCA:a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695–699.
16. ↵
    1. Adhikari T,
    2. Piatti A,
    3. Luggen M

    (2011) Cognitive dysfunction in SLE:development of a screening tool. Lupus 20, 1142–1146.
17. ↵
    1. Vitali C,
    2. Bombardieri S,
    3. Jonsson R,
    4. Moutsopoulos HM,
    5. Alexander EL,
    6. Carsons SE,
    7. et al.

    (2002) Classification criteria for Sjögren's syndrome:a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61, 554–558.
18. ↵
    1. Selekler K,
    2. Cangöz B,
    3. Uluç S

    (2010) Power of Discrimination of Montreal Cognitive Assessment (MOCA) Scale in Turkish Patients with Mild Cognitive Impairment and Alzheimer's Disease. Turkish Journal of Geriatrics 13, 166–171.
19. ↵
    1. Beck AT,
    2. Ward CH,
    3. Mendelson M,
    4. Mock J,
    5. Erbaugh J

    (1961) An inventory for measuring depression. Arch Gen Psychiatry 4, 561–571.
20. ↵
    1. Hisli N

    (1988) A study on the validity of the Beck Depression Inventory. Psikoloji Dergisi 6, 118–22.
21. ↵
    1. Scheltens P,
    2. Barkhof F,
    3. Leys D,
    4. Pruvo JP,
    5. Nauta JJ,
    6. Vermersch P,
    7. et al.

    (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114, 7–12.
22. ↵
    1. Alexander EL,
    2. Beall SS,
    3. Gordon B,
    4. Selnes OA,
    5. Yannakakis GD,
    6. Patronas N,
    7. et al.

    (1988) Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. Ann Intern Med 108, 815–823.
23. ↵
    1. Pierot L,
    2. Sauve C,
    3. Leger JM,
    4. Martin N,
    5. Koeger AC,
    6. Wechsler B,
    7. et al.

    (1993) Asymptomatic cerebral involvement in Sjögren's syndrome:MRI findings of 15 cases. Neuroradiology 35, 378–380.
24. ↵
    1. Barkhof F,
    2. Scheltens P

    (2002) Imaging of white matter lesions. Cerebrovasc Dis 13, 21–30.
25. ↵
    1. Segal BM,
    2. Pogatchnik B,
    3. Holker E,
    4. Liu H,
    5. Sloan J,
    6. Rhodus N,
    7. et al.

    (2012) Primary Sjogren's syndrome:cognitive symptoms, mood, and cognitive performance. Acta Neurol Scand 125, 272–278.